|
Astec Lifesciences Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
1447.53 Cr.
|
P/BV
|
3.50
|
Book Value (Rs.)
|
185.77
|
|
52 Week High/Low (Rs.)
|
1077/607
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
04/07/2025
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 378.15 | 457.70 | 628.17 | 676.57 | 554.87 |
| Other Operating Revenues | 3.16 | 0.48 | 0.00 | 0.00 | 0.00 |
| Total Operating Revenues | 381.30 | 458.18 | 628.17 | 676.57 | 554.87 |
| | | | | | |
| Other Income | 5.63 | 5.64 | 13.06 | 10.47 | 7.92 |
| Total Revenue | 386.93 | 463.82 | 641.23 | 687.03 | 562.79 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 248.86 | 318.82 | 460.83 | 444.82 | 344.60 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 48.08 | 0.46 | -59.59 | -58.00 | -2.55 |
| Employee Benefit Expenses | 61.10 | 61.74 | 52.26 | 50.31 | 38.35 |
| Finance Costs | 36.70 | 25.23 | 20.71 | 9.06 | 4.75 |
| Depreciation And Amortisation Expenses | 43.71 | 36.25 | 33.65 | 34.36 | 25.66 |
| Other Expenses | 89.47 | 83.07 | 98.41 | 85.37 | 62.92 |
| Total Expenses | 527.92 | 525.57 | 606.28 | 565.91 | 473.72 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -140.99 | -61.75 | 34.95 | 121.13 | 89.07 |
| | | | | | |
| Profit/Loss Before Tax | -140.99 | -61.75 | 34.95 | 121.13 | 89.07 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 0.04 | 0.04 | 0.03 | 28.63 | 23.26 |
| Deferred Tax | -6.32 | -14.89 | 9.33 | 2.61 | -0.61 |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 1.35 |
| Total Tax Expenses | -6.28 | -14.86 | 9.35 | 31.24 | 24.00 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -134.71 | -46.89 | 25.59 | 89.88 | 65.07 |
| | | | | | |
| Profit/Loss From Continuing Operations | -134.71 | -46.89 | 25.59 | 89.88 | 65.07 |
| | | | | | |
| Profit/Loss For The Period | -134.71 | -46.89 | 25.59 | 89.88 | 65.07 |
| | | | | | |
| Minority Interest | -0.04 | -0.04 | -0.03 | -0.02 | -0.02 |
| Consolidated Profit/Loss After MI And Associates | -134.75 | -46.93 | 25.56 | 89.86 | 65.05 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | -68.71 | -23.93 | 13.04 | 45.87 | 33.23 |
| Diluted EPS (Rs.) | -68.71 | -23.93 | 13.04 | 45.85 | 33.21 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 2.94 | 2.94 | 2.94 | 2.94 |
